LOT Supply and Delivery of DRUGS AND MEDICINES (Adenosine 3mg/ml, 2ml vial, etc.) for the use of Out Patient Department, Emergency Room, and Admitted Patients of DOPMC

Republic of the Philippines Province of Davao Oriental City of Mati BIDS & AWARDS COMMITTEE INVITATION TO BID LOT Supply and Delivery of DRUGS AND MEDICINES (Adenosine 3mg/ml, 2ml vial, etc.) for the use of Out Patient Department, Emergency Room, and Admitted Patients of DOPMC SOURCE OF FUND: General Fund [5-02-03-070] 1. The Provincial Government of Davao Oriental through the Bids and Awards Committee (BAC) intends to apply the sum of EIGHT MILLION SEVEN HUNDRED SEVENTY-FOUR THOUSAND FIVE HUNDRED NINETY-THREE PESOS (Php8,774,593.00) being the Approved Budget for Contract (ABC) payments under the contract for the LOT Supply and Delivery of DRUGS AND MEDICINES (Adenosine 3mg/ml, 2ml vial, etc.) for the use of Out Patient Department, Emergency Room, and Admitted Patients of DOPMC. Bids received in excess of the ABC shall be automatically rejected at Bid opening. 2. The Provincial Government of Davao Oriental now invites bids for the LOT Supply and Delivery of DRUGS AND MEDICINES (Adenosine 3mg/ml, 2ml vial, etc.) for the use of Out Patient Department, Emergency Room, and Admitted Patients of DOPMC. Delivery of the goods is within 30 Calendar days. Bidders should have completed, within 2 years from the date of submission and receipt of bids, a contract similar to the Project. The description of an eligible bidder is contained in the Bidding Documents, particularly in Section II- Instruction to Bidders. 3. Bidding will be conducted through open competitive bidding procedures using non-discretionary pass/fail criterion as specified in the Implementing Rules and Regulations (IRR) of Republic Act 12009 (R.A. 12009), otherwise known as the “New Government Procurement Reform Act”. 4. Interested Bidders may obtain further information from BAC Secretariat and inspect the bidding documents at the address given below during office hours. 5. A complete set of Bidding Documents may be purchased by interested bidders on October 26 – November 16, 2026 from the address below and upon payment of a non-refundable fee for the Bidding Documents in the amount of TEN THOUSAND PESOS (Php10,000.00). 6. The Provincial Government of Davao Oriental thru its BAC will hold a Pre-Bid Conference on November 3, 2026 at 2:00pm at the Bids and Awards Committee (BAC) Conference Room, Provincial Capitol Mansion, Capitol Hill, City of Mati, Davao Oriental. 7. Bids must be delivered to the address below on or before November 17, 2026 - 2:00pm. All bids must be accompanied by a Bid Security in any of the acceptable forms and in the amount stated in ITB Clause 18. Form of Bid Security - Cash or cashier’s/manager’s check issued by a Universal or Commercial Bank (2% of ABC) Minimum Amount - Php175,491.86 Form of Bid Security - Bank draft/guarantee or irrevocable letter of credit issued by a Universal or Commercial Bank. Provided, however, that it shall be confirmed or authenticated by a Universal or Commercial Bank, if issued by a foreign bank ( 5% of ABC) Minimum Amount - Php438,729.65 Form of Bid Security - Surety Bond callable upon demand issued by a surety or insurance company duly certified by the Insurance Commission as authorized to issue such security (5% of ABC) Minimum Amount - Php438,729.65 Form of Bid Security - Bid Securing Declaration 8. Bid opening shall be on November 17, 2026 - 2:00pm at the BAC Conference Room, Capitol Hill, City of Mati. Bids will be opened in the presence of the Bidders or their representatives who choose to attend. Late bids shall not be accepted. 9. The Provincial Government of Davao Oriental reserves the right to accept or reject any Bid, to annul the bidding process, and to reject all Bids at any time prior to contract award, without thereby incurring any liability to the affected Bidder or Bidders. 10. For further information, please refer to: ENGR. GISICA Y. SAYMANs Head, BAC Secretariat Provincial Capitol Mansion, Capitol Hill City of Mati, Davao Oriental Tel. No.: (087) 3883-353 Approved: ATTY. ARMAND B. DIOSO BAC Chairman Other Information 1. 10 Vial ADENOSINE 3 mg/mL, 2 mL vial 2. 750 Ampule/Vial AMIKACIN 125 mg/mL (as sulfate), 2 mL ampule/vial 3. 70 Ampule AMIODARONE 50 mg/mL (as hydrochloride), 3 mL ampule 4. 50 Ampule AMINOPHYLLINE 25 mg/mL, 10 mL ampule 5. 6,000 Vial AMPICILLIN 1 g (as sodium salt), vial 6. 6,000 Vial AMPICILLIN 250 mg (as sodium salt), vial 7. 1,100 Vial AMPICILLIN + SULBACTAM 1.5 g vial 8. 350 Vial AMPICILLIN + SULBACTAM 750 mg vial 9. 100 Ampule ATRACURIUM 10 mg/mL (as besilate) 2.5 mL ampule 10. 100 Ampule ATROPINE 1 mg/mL, 1 mL ampule (as sulfate) 11. 75 Ampule BUTORPHANOL 2 mg/mL (as tartrate), 1 mL ampule 12. 1,400 Ampule/Vial CALCIUM GLUCONATE 10% solution, 10 mL ampule/vial 13. 500 Vial CEFEPIME 1 g (as hydrochloride) vial 14. 400 Vial CEFOTAXIME 500 mg (as sodium salt), vial + 2 mL diluent 15. 350 Vial CIPROFLOXACIN 2 mg/mL (as lactate), 100 mL vial 16. 6,000 Ampule CLINDAMYCIN 150 mg/mL (as phosphate), 4 mL ampule 17. 10 Ampule CLONIDINE 150 mcg/mL (as hydrochloride), 1 mL ampule 18. 700 Ampule DEXAMETHASONE 4 mg/mL (as sodium phosphate), 2 mL ampule 19. 100 Ampule DIGOXIN 250 mcg/mL, 2 mL ampule 20. 300 Ampule DIPHENHYDRAMINE 50 mg/mL (as hydrochloride), 1 mL ampule 21. 800 Ampule DOBUTAMINE 50 mg/mL (as hydrochloride) 5mL ampule 22. 400 Ampule DOPAMINE 40 mg/mL (as hydrochloride), 5 mL ampule 23. 50 Tube ERYTHROMYCIN 0.5% eye ointment, 3.5 g tube 24. 70 Vial FLUCONAZOLE 2mg/mL, 100mL vial 25. 8,000 Ampule FUROSEMIDE 10 mg/mL, 2 mL ampule 26. 4,500 Ampule GENTAMICIN 40 mg/mL (as sulfate), 2 mL ampule 27. 6 Ampule HALOPERIDOL 5mg/mL, 1mL ampule 28. 20 Vial HEPARIN SODIUM 5,000 IU/mL, 5 mL vial 29. 400 Ampule HYDRALAZINE 20 mg/mL (as hydrochloride), 1 mL ampule 30. 6 Vial INSULIN GLARGINE 100 IU/mL in 3 mL pre-filled pen 31. 15,000 Nebule IPRATROPIUM + SALBUTAMOL 500 mcg + 2.5 mg x 2.5 mL nebule 32. 600 Ampule IRON SUCROSE 20 mg/mL, 5 mL ampule 33. 200 Ampule ISOSORBIDE DINITRATE 1 mg/mL, 10 mL ampule 34. 300 Ampule ISOXSUPRINE 5 mg/mL (as hydrochloride), 2 mL ampule 35. 9,000 Ampule KETOROLAC 30 mg/mL (as tromethamol), 1 mL ampule 36. 350 Vial LEVETIRACETAM 100 mg/mL, 5 mL Vial 37. 300 Vial LIDOCAINE 2% (as hydrochloride), 50 mL vial 38. 6 Bottle LIDOCAINE (as hydrochloride) 10%, 50 mL Spray 39. 1,500 Carpule LIDOCAINE 2% (as hydrochloride), 1.8 mL carpule (with epinephrine) (local infiltration) 40. 1,200 Ampule MAGNESIUM SULFATE 250 mg/mL (as heptahydrate), 10 mL ampule 41. 1,000 Ampule MAGNESIUM SULFATE 250 mg/mL (as heptahydrate), 20 mL vial 42. 1,200 Ampule METHYLERGOMETRINE 200 mcg/mL (as hydrogen maleate or maleate), 1 mL ampule 43. 6,500 Vial METRONIDAZOLE 5 mg/mL, 100 mL vial 44. 1,200 Ampule NICARDIPINE 1 mg/mL (as hydrochloride), 10 mL ampule 45. 10 Ampule NITROGLYCERIN (GLYCERYL TRINITRATE) 1 mg/mL, 10 mL Ampule 46. 1,500 Ampule NOREPINEPHRINE 1 mg/mL (as bitartrate) 4 mL ampule 47. 3,000 Ampule OXYTOCIN 10 IU/mL ampule, 1 mL ampule 48. 16,000 Ampule PARACETAMOL 150 mg/mL, 2 mL ampule 49. 20 Vial PENICILLIN G BENZATHINE 1,200,000 units (MR), vial 50. 150 Vial PENICILLIN G CRYSTALLINE 1 MU (as sodium salt) 51. 50 Vial PENICILLIN G CRYSTALLINE 5 MU (as sodium salt) 52. 400 Ampule PHENYTOIN 50 mg/mL (as sodium salt), 2 mL ampule 53. 1,800 Ampule PHYTOMENADIONE 10 mg/mL, 1 mL ampule 54. 700 Ampule POTASSIUM CHLORIDE 2 mEq/mL, 20 mL ampule 55. 120 Ampule/Vial PROPOFOL 10 mg/mL, 20 mL ampule/vial 56. 2,300 Ampule RANITIDINE (as hydrochlorothiazide) 25 mg/mL, 2 mL ampule 57. 5,000 Nebule SALBUTAMOL 2 mg/mL nebule (as sulfate), 2.5 mL 58. 18 Bottle SEVOFLURANE Inhalation: 250 mL bottle 59. 500 Tube SILVER SULFADIAZINE 1%, 25 g Cream Tube 60. 2,200 Ampule SODIUM BICARBONATE 1 mEq/mL, 20 mL vial 61. 50 Ampule SUXAMETHONIUM (SUCCINYLCHOLINE) 20 mg/mL, 10 mL vial (as chloride) 62. 4,000 Ampule TRAMADOL 50 mg/mL (as hydrochloride), 1 mL ampule 63. 120 Ampule VITAMIN B1 B6 B12 100 mg B1+ 100 mg B6+ 1 mg B12 per 3mL, ampule TERMS AND CONDITIONS: 1. Supplier is required to present/submit a valid certificate of product registration authorizing the registrant's marketing authority for said health product, pursuant to the License to Operate( LTO) issued by the Food and Drug Administration (FDA). 2. Pharmaceutical products must have a shelf life of twenty-four (24) months. However, deliveries with a minimum remaining shelf life of twelve (12) months from the date of delivery shall be accepted. Expired items shall be replaced by the supplier up to the twenty-fourth (24th) month of shelf life, based on the date of first delivery. 3. Pharmaceutical products for delivery shall be packed, handled, and stored in such a manner that prevents bacterial contamination, mix-ups, and cross-contamination, particularly for IV antibiotics, anesthetic/emergency drugs, and other biological preparations. 4. During transit, appropriate temperature and relative humidity conditions shall be maintained for thermolabile products and other pharmaceutical items requiring cold chain management. 5. When using dry ice in containers, special care must be observed to ensure that pharmaceutical products do not come into direct contact with the dry ice, as this may adversely affect product quality( e.g. by freezing). 6. For conformity with the items requested, bidders must specify in their price quotations the packaging content, product strength and preparation of the product for proper bid evaluation. 7. For traceability purposes of certain pharmaceutical products delivered, the supplier shall issue a charge invoice/delivery receipt indicating the expiry date and lot/batch number of each item. 8. In case of an adverse drug reaction report, samples for assay (FDA) shall be obtained from the remaining stocks. The bidder shall replace the unused quantity accordingly. 9. All outside packaging/boxes of pharmaceutical products for delivery shall be properly labeled for easier and faster identification. Labels shall include the product name, expiry date, lot/batch number, special storage conditions, and handling precautions. 10. The goods shall be delivered progressively within 30 days, commencing 7 days from receipt of Purchase order at DOPMC Pharmacy. 11. LOT BID 12. Any product found to have quality issues shall be replaced by the supplier at no additional cost to the procuring entity. Created by ATTY. ARMAND B DIOSO Date Created 26/10/2026 The PhilGEPS team is not responsible for any typographical errors or misinformation presented in the system. PhilGEPS only displays information provided for by its clients, and any queries regarding the postings should be directed to the contact person/s of the concerned party. ©&nbsp2004-2026 DBM Procurement Service. All rights reserved. Help | Contact Us | Sitemap